[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

Verzenio (abemaciclib) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Verzenio (abemaciclib) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the...

February 2020 50 pages

Vonvendi [von Willebrand factor (recombinant)] (US)/VEYVONDI [vonicog alfa, a recombinant human von Willebrand factor (rVWF)] (EU) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Vonvendi [von Willebrand factor (recombinant)] (US)/VEYVONDI [vonicog alfa, a recombinant human von Willebrand factor (rVWF)] (...

February 2020 50 pages

Vyzulta (latanoprostene bunod ophthalmic solution) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Vyzulta (latanoprostene bunod ophthalmic solution) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays co...

February 2020 50 pages

Xadago (safinamide) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Xadago (safinamide) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the pro...

February 2020 50 pages

Xifaxan (rifaximin) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Xifaxan (rifaximin) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the pro...

February 2020 50 pages

Zolgensma (onasemnogene abeparvovec-xioi) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Zolgensma (onasemnogene abeparvovec-xioi) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensi...

February 2020 50 pages

Acinetobacter Infections - Pipeline Insight, 2020

US$ 2,000.00

... clients within 5 Days 'Acinetobacter Infections - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acinetobacter Infections development. The report provides ...

January 2020 60 pages

Actinic Keratosis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Actinic Keratosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Actinic Keratosis development. The report provides ...

January 2020 90 pages

Acute Coronary Syndrome - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acute Coronary Syndrome The report also ...

January 2020 120 pages

Acute Lung Injury - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acute Lung Injury The report also ...

January 2020 60 pages

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acute Renal Failure (ARF) (Acute Kidney Injury) The report also ...

January 2020 90 pages

African Trypanosomiasis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'African Trypanosomiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across African Trypanosomiasis development. The report provides ...

January 2020 120 pages

Ageing - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Ageing - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ageing development. The report provides detailed ...

January 2020 90 pages

Alcohol Addiction - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Alcohol Addiction - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Alcohol Addiction development. The report provides ...

January 2020 60 pages

Allergic Conjunctivitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Allergic Conjunctivitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Allergic Conjunctivitis development. The report provides ...

January 2020 90 pages

Allergic Rhino-Conjunctivitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Allergic Rhino-Conjunctivitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Allergic Rhino-Conjunctivitis development. The report provides ...

January 2020 60 pages

Alopecia - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Alopecia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Alopecia development. The report provides detailed ...

January 2020 90 pages

Anaplastic Astrocytoma - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Anaplastic Astrocytoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anaplastic Astrocytoma development. The report provides ...

January 2020 90 pages

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Anaplastic Large Cell Lymphoma (ALCL) The report also ...

January 2020 120 pages

Anaplastic Thyroid Cancer - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Anaplastic Thyroid Cancer The report also ...

January 2020 60 pages

Anesthetic Effect - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Anesthetic Effect - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anesthetic Effect development. The report provides ...

January 2020 60 pages

Arterial Thrombosis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Arterial Thrombosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Arterial Thrombosis development. The report provides ...

January 2020 60 pages

Aspergillosis - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Aspergillosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Aspergillosis development. The report provides detailed ...

January 2020 60 pages

Ataxia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Ataxia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ataxia development. The report provides detailed ...

January 2020 60 pages

Autism - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Autism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Autism development. The report provides detailed ...

January 2020 60 pages

Bacterial Pneumonia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Bacterial Pneumonia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacterial Pneumonia development. The report provides ...

January 2020 60 pages

Bacterial (Pyogenic) Meningitis - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Bacterial (Pyogenic) Meningitis The report also ...

January 2020 60 pages

Behcet's Disease - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Behcet's Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Behcet's Disease development. The report provides ...

January 2020 60 pages

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2020

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Bile Duct Cancer (Cholangiocarcinoma) The report also ...

January 2020 60 pages

Biliary Tumor - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Biliary Tumor - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Biliary Tumor development. The report provides ...

January 2020 120 pages

Bipolar Disorder (Manic Depression) - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Bipolar Disorder (Manic Depression) The report also ...

January 2020 120 pages

Bladder Pain - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Bladder Pain - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bladder Pain development. The report provides ...

January 2020 120 pages

Bone Metastasis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Bone Metastasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bone Metastasis development. The report provides ...

January 2020 120 pages

Botulism - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Botulism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Botulism development. The report provides detailed ...

January 2020 60 pages

Brain Hemorrhage - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Brain Hemorrhage - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Hemorrhage development. The report provides ...

January 2020 60 pages

Brain Ischemia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Brain Ischemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Ischemia development. The report provides ...

January 2020 60 pages

Brain Metastasis - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Brain Metastasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Metastasis development. The report provides ...

January 2020 60 pages

Bronchiectasis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Bronchiectasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bronchiectasis development. The report provides detailed ...

January 2020 60 pages

Bronchopulmonary Dysplasia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Bronchopulmonary Dysplasia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bronchopulmonary Dysplasia development. The report provides ...

January 2020 120 pages

Candidiasis - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Candidiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Candidiasis development. The report provides detailed ...

January 2020 60 pages

Cataract - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Cataract - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cataract development. The report provides detailed ...

January 2020 60 pages

Chemotherapy Induced Anemia - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chemotherapy Induced Anemia The report also ...

January 2020 60 pages

Cholera - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Cholera - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cholera development. The report provides detailed ...

January 2020 60 pages

Choroidal Neovascularization - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Choroidal Neovascularization - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Choroidal Neovascularization development. The report provides ...

January 2020 60 pages

Chronic Back Pain - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Back Pain The report also ...

January 2020 60 pages

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Kidney Disease (Chronic Renal Failure) The report also ...

January 2020 90 pages

Chronic Plaque Psoriasis - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Plaque Psoriasis The report also ...

January 2020 60 pages

Chronic Stable Angina - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Stable Angina The report also ...

January 2020 60 pages

Cirrhosis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Cirrhosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cirrhosis development. The report provides detailed ...

January 2020 60 pages

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Clostridium Difficile Infections (Clostridium Difficile Associated Disease) The report also ...

January 2020 60 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers